Cargando…
Back From the Brink: The Uses of Targeting the CXCL10:CXCR3 Axis in Type 1 Diabetes
Autor principal: | Homann, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876762/ https://www.ncbi.nlm.nih.gov/pubmed/26604174 http://dx.doi.org/10.2337/dbi15-0019 |
Ejemplares similares
-
Back from the brink of obscurity
por: Vinh, Donald C
Publicado: (2018) -
Role of the transcription factor Fli-1 on the CXCL10/CXCR3 Axis*
por: Wang, Xuan, et al.
Publicado: (2023) -
Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury
por: Riedel, Jan-Hendrik, et al.
Publicado: (2023) -
Back from the brink: a mesenchymal stem cell infusion rescues kidney function in acute experimental rhabdomyolysis
por: Duffy, Michelle M, et al.
Publicado: (2014) -
Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review
por: Nazari, Alireza, et al.
Publicado: (2020)